Lv1
40 积分 2022-09-08 加入
A multiple imputation approach in enhancing causal inference for overall survival in randomized controlled trials with crossover
22小时前
已完结
Phase III Evaluation of Treatment Combinations in Three-Arm Trials
6天前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
7天前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
7天前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
7天前
已完结
A Toolkit for the Management of Protocol Deviations
17天前
已完结
The Life Cycle and Management of Protocol Deviations
17天前
已完结
Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting
17天前
已完结
Investigation of the Study Characteristics Affecting Clinical Trial Quality Using the Protocol Deviations Leading to Exclusion of Subjects From the Per Protocol Set Data in Studies for New Drug Application: A Retrospective Analysis
17天前
已完结
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma
22天前
已完结
皖公网安备34019202002308
